CHARLESTON, S.C., July 11, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) has been invited to exhibit at the Walter Reed Army Medical Center (WRAMC) Vendor Fair on Wednesday, July 13, 2011, in Washington, DC. Uniformed and civilian doctors, nurses, medical technicians, procurement officers and program managers that directly support our military personnel have all been invited to evaluate and demonstrate a select group of manufacturers' products during this event.
In September 2011, most WRAMC staff and patients will transition to the new National Naval Medical Center in Bethesda, MD, as part of the Base Realignment and Closure (BRAC) program. Thus, WRAMC will host this final vendor fair to ensure our nation's warfighters have access to the most innovative medical equipment and supplies available as U.S. Army staff officially integrates with U.S. Navy staff in the near term.
"The opportunity to demonstrate our RevVac auto retractable vacuum safety syringe to such a concentrated, dedicated and professional group of medical and military personnel at the Walter Reed Army Medical Center is tremendous," stated Chief Executive Officer and Chairman, Ron Wheet.
"We continue to support Revolutions Medical's efforts to enter and thrive within the military marketplace," stated Elvis Oxley, President of Oxley Consulting. He continued, "Our team is keenly focused on two prime agencies, the Department of Defense and Department of Veteran Affairs that have the most substantial medical equipment and supplies budgets across the federal spectrum. This event at Walter Reed will build on the contacts and successes earned through Revolutions Medical exhibiting at the Defense Logistics Agency's annual industry conference two weeks ago. We also owe a debt of gratitude to the US Army's Ft. Detrick Business Development Office; their team has been an outstanding advocate for this Company."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
About Oxley Consulting
Oxley Consulting, LLC provides capital partners, political intelligence and government marketing strategies to enterprise growth companies. We deliver quantifiable results for clients seeking to enhance their top line sales. We leverage our extensive network of Federal officials, corporate executives, and investors in order to capitalize on unique business opportunities that present themselves in Washington, DC, both governmental and commercial. Oxley, a SBA certified HUBZone small business, has been helping enterprise companies earn government sales since 2006. www.oxley-consulting.com.
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com
To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.